Initial public offering of Camurus AB (SE) on Nasdaq Stockholm — SEK 730 million

Carnegie acted as joint global co-ordinator and joint bookrunner in the initial public offering of Camurus on Nasdaq Stockholm. Camurus is a research and development based pharmaceutical company with a focus on the development and commercialisation of new and innovative pharmaceuticals for serious and chronic conditions, where there are clear medical needs and potential to significantly improve treatment. December 2015.